Literature DB >> 29554689

Cautions as Regulators Move to End Exclusive Reliance on Intention to Treat.

Miguel A Hernán1, Daniel Scharfstein2.   

Abstract

Mesh：

Year:  2018        PMID： 29554689     DOI： 10.7326/M17-3354

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Regulatory-grade clinical trial design using real-world data.

Authors:  Mark S Levenson
Journal:  Clin Trials       Date:  2020-02-17       Impact factor: 2.486

2.  The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.

Authors:  David M Kent; David van Klaveren; Jessica K Paulus; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2019-11-12       Impact factor: 25.391

3.  Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study.

Authors:  Md Belal Hossain; Lucy Mosquera; Mohammad Ehsanul Karim
Journal:  BMC Med Res Methodol       Date:  2022-02-16       Impact factor: 4.615

4.  Translating questions to estimands in randomized clinical trials with intercurrent events.

Authors:  Mats J Stensrud; Oliver Dukes
Journal:  Stat Med       Date:  2022-05-16       Impact factor: 2.497

5.  Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.

Authors:  Marian Mitroiu; Steven Teerenstra; Katrien Oude Rengerink; Frank Pétavy; Kit C B Roes
Journal:  Pharm Stat       Date:  2022-06-09       Impact factor: 1.234

6.  Counterfactual prediction is not only for causal inference.

Authors:  Barbra A Dickerman; Miguel A Hernán
Journal:  Eur J Epidemiol       Date:  2020-07       Impact factor: 8.082
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.